Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
96pct
375d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 or the SITSA Act This bill amends the Controlled Substances Act to establish a new, sixth schedule of controlled substances—schedule A. A drug or substance in schedule A has a chemical structure that is similar to, and an effect on the body that is similar to or greater than, a controlled substance in schedule I, II, III, IV, or V. The bill adds 13 synthetic fentanyl-related substances to schedule A. It also authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently place a drug or substance in schedule A. The bill establishes criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute a schedule A substance. However, it explicitly prohibits criminal and civil penalties solely for possession of a schedule A controlled substance. The bill makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a schedule A substance that is not clearly labeled. Finally, it establishes new, separate DEA registration requirements for manufacturers, distributors, and importers and exporters of schedule A substances.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (22)
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by recorded vote: 239 - 142 (Roll no. 268).
HousePassed/agreed to in House: On passage Passed by recorded vote: 239 - 142 (Roll no. 268).
HouseThe House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.
The previous question was ordered pursuant to the rule.
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 2851.
DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Thornberry amendment No. 4.
DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Sean Maloney amendment No. 3.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2018 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 695/S. 705, the Child Protection Improvements Act, which would allow organizations that serve children and the elderly to use the FBI database to conduct background checks on potential employees; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1865/S. 1693, the Allow States and Victims to Fight Online Sex Trafficking Act, which would to update and clarify Section 230 of the Communications Decency Act to ensure that charges can be brought against interactive computer service providers who engage in criminal behavior or with reckless disregard to criminal activity; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3249, the Project Safe Neighborhoods Grant Program Authorization Act, would reauthorize and fully fund the Project Safe Neighborhoods program; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4477/S. 2135, the "Fix NICS Act, would require all Federal agencies and States to produce NICS implementation plans focused on uploading accurate, required information to the background check system; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office
2018 · fourth_quarter · Alcohol and Drug Abuse
H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018 S.2680-Opioid Crisis Response Act of 2018
Client expense: $549,617 · Firm income: Not reported
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.4922-Stopping Overdoses of Fentanyl Analogues Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act
Client expense: $549,617 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2018 · fourth_quarter · Health Issues
Essential emergency medication shortages Mental health services for emergency psychiatric patients Price transparency, out-of-network reimbursement of emergency medical services H.Res.906-Congratulating the American College of Emergency Physicians on its 50th anniversary H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.372-Competetive Health Insurance Reform Act of 2017 H.R.548-Health Care Safety Net Enhancement Act of 2017 H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.817-End Surprise Billing Act of 2017 H.R.880-Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1215-Protecting Access to Care Act of 2017 H.R.1323-Reducing Unnecessary Emergency Room Visits under Medicaid Act H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.1565-Saving Lives, Saving Costs Act H.R.1822-Good Samaritan Health Professionals Act of 2017 H.R.1876-Good Samaritan Health Professionals Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2410-Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.2957-Save Rural Hospitals Act H.R.3181-Medicare Choices Empowerment and Protection Act H.R.3258-Marketplace Certainty Act H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.5678-Rural Emergency Medical Center Act of 2018 H.R.5734-Resident Education Deferred Interest Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act H.R.6143-Patient Right to Know Drug Prices Act H.R.6144-Know the Lowest Price Act of 2018 H.R.6372-To require the Secretary of Health and Human Services issue regulations to ensure due process rights for physicians furnishing emergency medical services H.R.6502-Reducing Unnecessary Senior Hospitalizations Act of 2018 H.R.6615-Traumatic Brain Injury Program Reauthorization Act of 2018 H.R.6733-Know the Cost Act of 2018 H.R.6748-Emergency Medical Services for Children Program Reauthorization Act of 2018 H.R.7223-Right Rebate Act of 2018 Senate resolution congratulating the American College of Emergency Physicians on its 50th anniversary S.191-Patient Freedom Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.284-End Surprise Billing Act of 2017 S.372- Synthetics Trafficking and Overdose Prevention Act of 2017 S.527-Health Care Safety Net Enhancement Act of 2017 S.568-Improving Access to Medicare Coverage Act of 2017 S.781-Good Samaritan Health Professionals Act of 2017 S.1016-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017 S.1022-Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act S.1130-Rural Emergency Acute Care Hospital (REACH) Act S.1462-Marketplace Certainty Act S.1530- Medicare Choices Empowerment and Protection Act S.1553-Stopping Overdoses of Fentanyl Analogues Act S.1835-Lower Premiums Through Reinsurance Act of 2017 S.2465-Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2544-Patient Right to Know Drug Prices Act S.2553-Know the Lowest Price Act of 2018 S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018 S.2680-Opioid Crisis Response Act of 2018 S.3482-Emergency Medical Services for Children Program Reauthorization Act of 2018 S.3531-Emergency Care Improvement Act S.3657-Traumatic Brain Injury Program Reauthorization Act of 2018 S.3702-Right Rebate Act of 2018
2018 · second_quarter · Law Enforcement/Crime/Criminal Justice
Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); Ending the Fentanyl Crisis Act (S.2635); Building America's Trust Act (S. 1757); Securing America's Future Act (H.R. 4760); NDAA (H.R. 5515); Immigration Policy; Mens Rea Reform Act (S. 3118); House Farm Bill (H.R. 2) - provisions re. SNAP; Protect and Serve Act (H.R. 5693, S. 2794)
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Jackson Lee amendment No. 2.
DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Griffith amendment No. 1.
GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 2851.
The Speaker designated the Honorable Mike Bost to act as Chairman of the Committee.
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 934 and Rule XVIII.
Rule provides for consideration of H.R. 2851, H.R. 5735 and H.R. 5788 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.
Considered under the provisions of rule H. Res. 934. (consideration: CR H5204-5221; text of amendment in the nature of a substitute: CR H5212-5215)
Rules Committee Resolution H. Res. 934 Reported to House. Rule provides for consideration of H.R. 2851, H.R. 5735 and H.R. 5788 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Specified amendments are in order.
Reported (Amended) by the Committee on Judiciary. H. Rept. 115-713, Part I.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Referred to |
| June 8, 2017 |
| Energy and Commerce Committee | House | Referred to | June 8, 2017 |
| Republican |
| PA |
| Blake Farenthold | Republican | TX |
| Bob Goodlatte | Republican | VA |
| Bradley Byrne | Republican | AL |
| Brian J. Mast | Republican | FL |
| Brian K. Fitzpatrick | Republican | PA |
| Carlos Curbelo | Republican | FL |
| Charles J. "Chuck" Fleischmann | Republican | TN |
| Chris Collins | Republican | NY |
| Claudia Tenney | Republican | NY |
| Daniel M. Donovan, Jr. | Republican | NY |
| David B. McKinley | Republican | WV |
| David P. Joyce | Republican | OH |
| David P. Roe | Republican | TN |
| David Rouzer | Republican | NC |
| Diane Black | Republican | TN |
| Elise M. Stefanik | Republican | NY |
| Evan H. Jenkins | Republican | WV |
| F. James Sensenbrenner, Jr. | Republican | WI |
| Filemon Vela | Democratic | TX |
| Frank A. LoBiondo | Republican | NJ |
| Fred Upton | Republican | MI |
| Glenn Thompson | Republican | PA |
| Grace F. Napolitano | Democratic | CA |
| Greg Walden | Republican | OR |
| John H. Rutherford | Republican | FL |
| John J. Faso | Republican | NY |
| John R. Curtis | Republican | UT |
| Josh Gottheimer | Democratic | NJ |
| Karen C. Handel | Republican | GA |
| Kathleen M. Rice | Democratic | NY |
| Keith J. Rothfus | Republican | PA |
| Kevin Cramer | Republican | ND |
| Kyrsten Sinema | Independent | AZ |
| Lamar Smith | Republican | TX |
| Lee M. Zeldin | Republican | NY |
| Lloyd Smucker | Republican | PA |
| Lou Barletta | Republican | PA |
| Mario Diaz-Balart | Republican | FL |
| Marsha Blackburn | Republican | TN |
| Martha McSally | Republican | AZ |
| Michael R. Turner | Republican | OH |
| Michael T. McCaul | Republican | TX |
| Mike Bishop | Republican | MI |
| Mike Bost | Republican | IL |
| Mike Gallagher | Republican | WI |
| Mike Kelly | Republican | PA |
| Patrick Meehan | Republican | PA |
| Paul Mitchell | Independent | MI |
| Pete Olson | Republican | TX |
| Pete Sessions | Republican | TX |
| Peter T. King | Republican | NY |
| Ralph Norman | Republican | SC |
| Richard E. Neal | Democratic | MA |
| Ryan A. Costello | Republican | PA |
| Scott DesJarlais | Republican | TN |
| Scott Perry | Republican | PA |
| Stephen Knight | Republican | CA |
| Steve Chabot | Republican | OH |
| Steve Stivers | Republican | OH |
| Susan W. Brooks | Republican | IN |
| Ted Budd | Republican | NC |
| Ted S. Yoho | Republican | FL |
| Thomas J. Rooney | Republican | FL |
| Thomas MacArthur | Republican | NJ |
| Thomas R. Suozzi | Democratic | NY |
| Tom Marino | Republican | PA |
| Tom Reed | Republican | NY |
| Trey Gowdy | Republican | SC |
| Vern Buchanan | Republican | FL |
| Vicente Gonzalez | Democratic | TX |
| Vicky Hartzler | Republican | MO |
| HR 6047 |
115th |
| Related bill |
| HR 6 | 115th | Related bill |
| HR 5531 | 115th | Related bill |
| HR 5021 | 115th | Related bill |
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Client expense: $549,617 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R.5682 / S.2795 - FIRST STEP Act H.R.2851 / S.1327 - SITSA Act H.R.2899 / S.3635 - Second Chance Reauthorization Act of 2017 H.R.254 - REAL Act of 2017 H.R.1809 - Juvenile Justice Reform Act of 2017 S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions S. 860 - Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions S.1856 / H.R.1556 - Stop Militarizing Law Enforcement Act S.827 / H.R.1906 - REDEEM Act S.756 - FIRST STEP Act (vehicle that became law) S.3635 - Second Chance Reauthorization Act of 2018 Package of campaign finance reforms as yet to be introduced in the House of Representatives
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.4922-Stopping Overdoses of Fentanyl Analogues Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act
Client expense: $402,721 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Essential emergency medication shortages Mental health services for emergency psychiatric patients Price transparency, out-of-network reimbursement of emergency medical services H.Res.906-Congratulating the American College of Emergency Physicians on its 50th anniversary H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.372-Competetive Health Insurance Reform Act of 2017 H.R.548-Health Care Safety Net Enhancement Act of 2017 H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.817-End Surprise Billing Act of 2017 H.R.880-Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1215-Protecting Access to Care Act of 2017 H.R.1323-Reducing Unnecessary Emergency Room Visits under Medicaid Act H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.1565-Saving Lives, Saving Costs Act H.R.1822-Good Samaritan Health Professionals Act of 2017 H.R.1876-Good Samaritan Health Professionals Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2410-Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.2957-Save Rural Hospitals Act H.R.3181-Medicare Choices Empowerment and Protection Act H.R.3258-Marketplace Certainty Act H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.5678-Rural Emergency Medical Center Act of 2018 H.R.5734-Resident Education Deferred Interest Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act H.R.6143-Patient Right to Know Drug Prices Act H.R.6144-Know the Lowest Price Act of 2018 H.R.6372-To require the Secretary of Health and Human Services issue regulations to ensure due process rights for physicians furnishing emergency medical services H.R.6502-Reducing Unnecessary Senior Hospitalizations Act of 2018 H.R.6733-Know the Cost Act of 2018 Senate resolution congratulating the American College of Emergency Physicians on its 50th anniversary S.191-Patient Freedom Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.284-End Surprise Billing Act of 2017 S.372- Synthetics Trafficking and Overdose Prevention Act of 2017 S.527-Health Care Safety Net Enhancement Act of 2017 S.568-Improving Access to Medicare Coverage Act of 2017 S.781-Good Samaritan Health Professionals Act of 2017 S.1016-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017 S.1022-Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act S.1130-Rural Emergency Acute Care Hospital (REACH) Act S.1462-Marketplace Certainty Act S.1530- Medicare Choices Empowerment and Protection Act S.1553-Stopping Overdoses of Fentanyl Analogues Act S.1835-Lower Premiums Through Reinsurance Act of 2017 S.2465-Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2544-Patient Right to Know Drug Prices Act S.2553-Know the Lowest Price Act of 2018 S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018 S.2680-Opioid Crisis Response Act of 2018 S.3531-Emergency Care Improvement Act
Client expense: $402,721 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Alcohol and Drug Abuse
H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018 S.2680-Opioid Crisis Response Act of 2018
Client expense: $402,721 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Preventing Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal funding from so-called sanctuary cities; H.R. 3089/S. 1454/S. 1717, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of Transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
S. 756, Save Our Seas Act (First Step Act) S. 3649, First Step Act H.R.2851, SITSA Act
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 H.R.4825/S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 Public Law 115-271, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act H.R.5634, Medical Cannabis Research Act of 2018 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · fourth_quarter · Health Issues
No bill, lobbied to raise awareness about Atrial Fibrillation and stroke prevention. No bill, lobbied regarding biosimilars issues including naming, labeling and interchangeability. H.R. 1245 and S. 469, Affordable and Safe Prescription Drug Importation Act, lobbied regarding all biopharmaceutical provisions. H.R. 1703, Medical Product Communications Act of 2017, regarding all biopharmaceutical related provisions H.R. 2851, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017, regarding all biopharmaceutical related provisions No bill, lobbied for changes to the 340B Drug Discount Program. H.R. 4710, 340B PAUSE Act, lobbied regarding all biopharmaceutical provisions. H.R. 4392, a bill to repeal the HOPPS final regulation related to changes in the payment amount for certain drugs under the 340B program, lobbied regarding all biopharmaceutical provisions. H.R. 2026, the Pharmaceutical Information Exchange (PIE) Act of 2017, lobbied regarding all biopharmaceutical provisions. S. 2312, Helping Ensure Low-Income Patients have Access to Care and Treatment (HELP) Act, regarding all biopharmaceutical related provisions. S.2453, Ensuring the Value of the 340B Program Act of 2018, regarding all biopharmaceutical related provisions. H.R. 5598 340B Optimization Act, regarding all biopharmaceutical related provisions. H.R. 6071 SERV Communities Act, regarding all biopharmaceutical related provisions. H.R. 6240, Drug Discount Accountability Act, regarding all biopharmaceutical related provisions. H.R. 6143, S. 2554, Patient Right to Know Drug Prices Act, regarding all biopharmaceutical related provisions. H.R. 6, SUPPORT for Patients and Communities Act, regarding all biopharmaceutical related provisions.
Client expense: $940,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R.5682 / S.2795 - FIRST STEP Act H.R.2851 / S.1327 - SITSA Act H.R.2899 / S.3635 - Second Chance Reauthorization Act of 2017 H.R.254 - REAL Act of 2017 H.R.1809 - Juvenile Justice Reform Act of 2017 S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions S. 860 - Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions S.1856 / H.R.1556 - Stop Militarizing Law Enforcement Act S.827 / H.R.1906 - REDEEM Act S.756 - FIRST STEP Act (vehicle that became law) S.3635 - Second Chance Reauthorization Act of 2018 Package of campaign finance reforms as yet to be introduced in the House of Representatives
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); NDAA (H.R. 5515); Mens Rea Reform Act (S. 3118); House Farm Bill (H.R. 2) - provisions re. SNAP; Senate Transportation and Housing (THUD) appropriations bill (S. 3023) - provision re: individuals with certain convictions and public housing benefits; Consumer Data Protection Act of 2018 (Wyden discussion draft); money laundering; First Step Act (S. 3649) - all provisions; pretrial release/bail
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 5682/S. 3649/S. 756, First Step Act (prison and sentencing reform); mandatory minimum sentencing reform; H.R. 2851/S. 1327 SITSA Act (re: new schedules and sentences for drug analogues; USSC priorities; S. 3588, PREP Act (Prison education bill); H.R. 6697/S. 3335, Restoring the Armed Career Criminal Act (expands existing mandatory minimums); H.R. 7113, Combat Violent Crime Act (expands existing mandatory minimums); oversight of BOP
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Government Issues
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms Supporting the reclassification of hemp out of Schedule I of the Controlled Substances Act; Inclusion of hemp reclassification in the Farm Bill
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Consumer Issues/Safety/Products
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms Supporting the reclassification of hemp out of Schedule I of the Controlled Substances Act; Inclusion of hemp reclassification in the Farm Bill
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms Supporting the reclassification of hemp out of Schedule I of the Controlled Substances Act; Inclusion of hemp reclassification in the Farm Bill
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Preventing Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454/S. 1717, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of Transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office
2018 · third_quarter · Health Issues
H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 749: Lower Drug Costs through Competition Act - Provisions related to generic drug approvals H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 1628: American Health Care Act of 2017 - Provisions related to the biopharmaceutical industry including repeal of brand pharmaceutical manufacturer fee and individual and employer mandates, insurance affordability provisions, and Medicaid reforms H.R. 1776: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 - Provisions related to labeling information describing abuse-deterrent properties H.R. 2051: FAST Generics Act of 2017 - Provisions related to REMS and limited distribution systems H.R. 2063: Opioid Preventing Abuse through Continuing Education (PACE) Act of 2017 - Provisions related to prescriber training H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 2851: Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act - Provisions related to controlled substances H.R. 3545: Overdose Prevention and Patient Safety Act - Provisions related to substance use disorder records H.R. 3692: Addiction Treatment Access Improvement Act of 2017 - Provisions related to medication assisted treatment (MAT) access H.R. 4275: Empowering Pharmacists in the Fight Against Opioid Abuse Act - Provisions related to pharmacist education H.R. 4284: Indexing Narcotics, Fentanyl, and Opioids (INFO) Act of 2018 - Provisions related to substance use disorder information H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program H.R. 4482: Opioid Abuse Deterrence, Research, and Recovery Act of 2017 - Provisions related to prescriber requirements H.R. 5002: Advancing Cutting Edge Research Act - Provisions related to non-addiction pain medication H.R. 5009: Jessies Law - Provisions related to patient information H.R. 5041: The Safe Disposal of Unused Medication Act - Provisions related to drug disposal H.R. 5102: Substance Use Disorder Workforce Loan Repayment Act of 2018 - Provisions related to loan repayment program H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 - Provisions related to drug delivery H.R. 5228: SCREEN Act - Provisions related to drug recall authority H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5327: Comprehensive Opioid Recovery Centers Act of 2018 - Provisions related to opioid recovery center grants H.R. 5329: Poison Center Network Enhancement Act of 2018 - Provisions related to national poison center funding and other prevention funding H.R. 5582: Abuse Deterrent Access Act of 2018 H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5687: SOUND Disposal and Packaging Act - Provisions related to packaging and disposal methods with respect to certain drugs H.R. 5752: Stop Illicit Importation Act of 2018 - Provisions related to importation H.R. 5762: Joint Task Force to Combat Opioid Trafficking Act of 2018 - To authorize a Joint Task Force to enhance integration of the Department of Homeland Securitys border security operations to detect, interdict, disrupt, and prevent narcotics, such as fentanyl and other synthetic opioids, from entering the United States H.R. 5788: Synthetics Trafficking and Overdose Prevention Act of 2018 or STOP Act of 2018 H.R. 5803: SAFETY Act of 2018 - Provisions related to drug approval H.R. 5811: Long-Term Opioid Efficacy Act of 2018 - Postapproval study requirements H.R. 6143: Patient Right to Know Drug Prices Act - Provisions related to drug pricing H. Res. 949: Providing for consideration of the bill (H.R. 6) to provide for opioid use disorder prevention, recovery, and treatment, and for other purposes; providing for consideration of the bill (H.R. 5797) to amend title XIX of the Social Security Act to allow States to provide under Medicaid services for certain individuals with opioid use disorders in institutions for mental diseases; and providing for consideration of the bill (H.R. 6082) to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 771: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 - Provisions related to drug pricing S. 1327: SITSA Act - Provisions related to controlled substances S. 2157: Drug-Price Transparency in Communications Act S. 2312: HELP Act - Provisions related to 340B program S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program S. 2553: Know the Lowest Price Act of 2018 - Provisions related to drug pricing S. 2554: Patient Right to Know Drug Prices Act - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety S. 2680: Opioid Crisis Response Act of 2018 - Provisions related to opioids S. 3428: Lessening Addiction by Enhancing Labeling Opiods Act of 2018 S. 3519: A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Generic drug approval process policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug compounding policy issues including federal oversight of compounded drugs Cancer drug vial size policy issues TRICARE pharmacy pilot program Drug shortages policy issues Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49)
Client expense: $5,990,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
2018 · third_quarter · Health Issues
H.R. 6, SUPPORT for Patients and Communities Act, H.R. 2851
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
Client expense: $87,644 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018 H.R.6, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act Marijuana and Cannabidiol Research Expansion Act H.R.5634, Medical Cannabis Research Act of 2018
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Alcohol and Drug Abuse
S. 1327, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R. 2851, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R.993, Opioid Abuse Prevention and Treatment Act of 2017 H.R. 1732, Synthetic Drug Control Act of 2017 H.R.5298, Modernizing Drug Enforcement Act of 2018
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Government Issues
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms Supporting the reclassification of hemp out of Schedule I of the Controlled Substances Act; Inclusion of hemp reclassification in the Farm Bill
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms Supporting the reclassification of hemp out of Schedule I of the Controlled Substances Act; Inclusion of hemp reclassification in the Farm Bill
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms Supporting the reclassification of hemp out of Schedule I of the Controlled Substances Act; Inclusion of hemp reclassification in the Farm Bill
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
No bill, lobbied to raise awareness about Atrial Fibrillation and stroke prevention. No bill, lobbied regarding biosimilars issues including naming, labeling and interchangeability. H.R. 1245 and S. 469, Affordable and Safe Prescription Drug Importation Act, lobbied regarding all biopharmaceutical provisions. H.R. 1703, Medical Product Communications Act of 2017, regarding all biopharmaceutical related provisions H.R. 2851, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017, regarding all biopharmaceutical related provisions No bill, lobbied for changes to the 340B Drug Discount Program. H.R. 4710, 340B PAUSE Act, lobbied regarding all biopharmaceutical provisions. H.R. 4392, a bill to repeal the HOPPS final regulation related to changes in the payment amount for certain drugs under the 340B program, lobbied regarding all biopharmaceutical provisions. H.R. 2026, the Pharmaceutical Information Exchange (PIE) Act of 2017, lobbied regarding all biopharmaceutical provisions. S. 2312, Helping Ensure Low-Income Patients have Access to Care and Treatment (HELP) Act, regarding all biopharmaceutical related provisions. S.2453, Ensuring the Value of the 340B Program Act of 2018, regarding all biopharmaceutical related provisions. H.R. 5598 340B Optimization Act, regarding all biopharmaceutical related provisions. H.R. 6071 SERV Communities Act, regarding all biopharmaceutical related provisions. H.R. 6240, Drug Discount Accountability Act, regarding all biopharmaceutical related provisions. H.R. 6143, S. 2554, Patient Right to Know Drug Prices Act, regarding all biopharmaceutical related provisions. H.R. 6, SUPPORT for Patients and Communities Act, regarding all biopharmaceutical related provisions.
Client expense: $960,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Law Enforcement/Crime/Criminal Justice
S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions S. 860 - Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions H.R.1809 - Juvenile Justice Reform Act of 2017 H.R.5682 / S.2795 - FIRST STEP Act H.R.2851 / S.1327 - SITSA Act H.R.2899 - Second Chance Reauthorization Act of 2017 (and not yet reintroduced Senate companion) S.1856 / H.R.1556 - Stop Militarizing Law Enforcement Act S.827 / H.R.1906 - REDEEM Act H.R.254 - REAL Act of 2017 Package of campaign finance reforms as yet to be introduced in the House of Representatives
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Drug pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; CREATES Act (HR 2212/S. 974; 340B issues; SUPPORT for Patients and Communities Act (H.R. 6), Biosimilars Competition Act of 2018 (H.R. 6478), Patient Right to Know Drug Prices Act (S. 2554/H.R. 6143), Re-Valuing Anti-Microbial Products Act of 2018 (H.R. 6294), Medicare Negotiation and Competitive Licensing Act of 2018 (H.R. 6505), Making Objective Drug Evidence Revisions for New (MODERN) Labeling Act (S. 3519), citizen petitions
Client expense: Not reported · Firm income: $270,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Law Enforcement/Crime/Criminal Justice
Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); NDAA (H.R. 5515); Immigration Policy; Mens Rea Reform Act (S. 3118); House Farm Bill (H.R. 2) - provisions re. SNAP; Community Safety and Security Act (H.R. 6691) - all provisions; Empowering Financial Institutions to Fight Human Trafficking Act (H.R. 6729); Senate Transportation and Housing (THUD) appropriations bill (S. 3023) - provision re: individuals with certain convictions and public housing benefits; Medical Cannabis Research Act of 2018 (H.R. 5634)
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 2851/S. 1327, SITSA Act (new schedules and sentences for drug analogues); H.R. 6 (opioid bill); mandatory minimum sentencing reform; H.R. 3356, Prison Reform and Redemption Act (prison reform); H.R. 5682, FIRST STEP Act (prison reform); compassionate release; S. 1917, Sentencing Reform and Corrections Act (sentencing and prison reform); S. 2471, GRACE Act (compassionate release); U.S. Sentencing Commission nominations; S. 2635 (changes to fentanyl penalties); H.R. 6691 (changes to crime of violence definition); H.R. 6697/S. 3335 (changes to Armed Career Criminal Act)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.4922-Stopping Overdoses of Fentanyl Analogues Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act
Client expense: $702,392 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2018 · second_quarter · Health Issues
Essential emergency medication shortages Mental health services for emergency psychiatric patients Price transparency of emergency medical services Due process rights for physicians furnishing emergency medical services H.Res.906-Congratulating the American College of Emergency Physicians on its 50th anniversary H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.372-Competetive Health Insurance Reform Act of 2017 H.R.548-Health Care Safety Net Enhancement Act of 2017 H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.817-End Surprise Billing Act of 2017 H.R.880-Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1215-Protecting Access to Care Act of 2017 H.R.1323-Reducing Unnecessary Emergency Room Visits under Medicaid Act H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.1565-Saving Lives, Saving Costs Act H.R.1822-Good Samaritan Health Professionals Act of 2017 H.R.1876-Good Samaritan Health Professionals Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.2957-Save Rural Hospitals Act H.R.3181-Medicare Choices Empowerment and Protection Act H.R.3258-Marketplace Certainty Act H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.5678-Rural Emergency Medical Center Act of 2018 H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act S.191-Patient Freedom Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.284-End Surprise Billing Act of 2017 S.372- Synthetics Trafficking and Overdose Prevention Act of 2017 S.527-Health Care Safety Net Enhancement Act of 2017 S.568-Improving Access to Medicare Coverage Act of 2017 S.781-Good Samaritan Health Professionals Act of 2017 S.1016-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017 S.1022-Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act S.1130-Rural Emergency Acute Care Hospital (REACH) Act S.1462-Marketplace Certainty Act S.1530- Medicare Choices Empowerment and Protection Act S.1553-Stopping Overdoses of Fentanyl Analogues Act S.1835-Lower Premiums Through Reinsurance Act of 2017 S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018
Client expense: $702,392 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2018 · second_quarter · Alcohol and Drug Abuse
H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018
Client expense: $702,392 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2018 · second_quarter · Law Enforcement/Crime/Criminal Justice
Support the reauthorization of Byrne JAG grants Oppose the Department of Justices request for a new citizenship question on the 2020 Census Support full funding of critical juvenile justice and delinquency prevention programs in fiscal year 2019 Support S. 1917, with reservations about new mandatory minimums imposed by the bill Support a more robust response to the hate violence and groups that flourish on social media platforms, dont just focus on Muslim extremists Support the federal governments crucial role in spurring criminal justice innovation, as well as testing and replicating evidence-based practices nationwide by funding programs including the Office of Violence Against Women and the COPS program Support appropriating $95 million in FY2019 to the Department of Labor for its Reintegration of Ex-Offenders program Support an independent Community Relations Service (CRS); oppose the Trump proposal to move CRS under the Department of Justice Office of Civil Rights Oppose the Presidents proposal calling for increasing sentences for drug offenders, including the death penalty. S.1994, the CORRECTIONS Act, and H.R. 3356, the Prison Reform and Redemption Act, are not sentencing reform and should not be viewed as such. This legislation will not, alone, substantially alleviate prison overcrowding or mass incarceration Oppose mandatory arbitration clauses for investors; support the SEC protecting investors rights to bring securities class action lawsuits Support proposals to build trust between law enforcement and the communities they serve. Support initiatives to standardize use of force policies for law enforcement. support ending racial and religious profiling. Support H.R. 1498 / S. 411 Support initiatives to study and eventually eliminate prosecutorial misconduct / bias. support the establishment of local effective and independent review boards of alleged law enforcement misconduct. Support requiring video surveillance of all law enforcement activities Support genuine sentencing reform to alleviate prison overcrowding, over-incarceration, and the overrepresentation of racial and ethnic minorities who are in prison. Support HR 4261 Support a commission to review all aspects of our national criminal justice system. Support H.R. 1886 / S.573 Support ending the ban on CDC Gun Research Support requiring universal background checks on all gun sales and transfers support a ban on the sale of all military-style semi-automatic assault guns and military high capacity ammunition clips (support HR 5078 / S. 2095 and S. 1945 Support tough new criminal penalties for straw purchasers and gun traffickers Support a ban on suspects on the terror watch list from purchasing firearms Support the Fix NICS Act (H.R. 4434 / S. 2135). Incentivize and assist states in improving their overall reporting to the National Instant Criminal Background Check System (NICS) Support sensitivity training of law enforcement & independent investigations of deadly force (HR 1870 / S 860)Support maintaining current law requiring background checks and permits for gun silencers. Support a ban on bump stocks machine-gun type firing and other conversion kits, accessories and parts Support allowing states to maintain and enforce their own concealed carry laws Support requiring the repeal of all state stand your ground laws, restoring the use of deadly force as a last resort Support microstamping or ballistic fingerprinting of all new firearms and ammunition sold in the U.S. support encouraging local jurisdictions to utilize their buyer power to create incentives for firearm manufacturers to employ countermarketing strategies to ensure that their retailers are using all available procedures to prevent illegal firearms diversion Support an abolishment of the death penalty Support the Second Chance Act reauthorization (HR 2899) Support the reauthorization and updating of the Juvenile Justice Delinquency Prevention Act(support HR 1809 / S 860 Support the reform of money bail (HR 4019 / S 1593) Support incentivizing states and local jurisdictions to fully and accurately report hate crimes (HR 1566 / S. 667) Support the removal of statues of Confederate soldiers from the U.S. Capital (support HR 3701 / S 1772) Support encouraqing states to decrease prison populations and keep crime down (support HR 3845 / S 1458) Support the Compensating Legacy Artists for their Songs, Service, and Important Contributions to Society (CLASSICS) Act (H.R. 3301/S. 2393), bipartisan and which ensures legacy musicians are compensated when their work is played on digital radio platforms. Oppose the nomination of Thomas Farr to the Federal Court for the Eastern District of North Carolina Support the inclusion of provisions to: final federal legislation to: Curtail the ballooning number of federal regulatory crimes; eliminate federal criminal penalties for simple drug possession in state jurisdictions; promote targeted sentencing of drug offenders, ensuring that violent and career criminals and crime leaders and organizers are held accountable; update supervision policies to more effectively change the criminal behavior of the nearly 132,000 on probation and post-prison supervision; increase government transparency and accountability by requiring public disclosure of regulatory criminal offenses; allowing victims of regulatory over-criminalization to contact the inspector general; protecting against wrongful convictions; encourage judicial districts to open drug, veteran, mental health and other problem solving courts; reinvest the substantial savings by investing in communities, prevention, and intervention initiatives and state, local, and federal law enforcement and prosecutors reduce recidivism by using swift and certain responses so offenders know what will happen if they re-offend or act in a certain way; create a system of rewards and incentives for good behavior; and acknowledge that age matters by implementing smart, targeted geriatric release programs which can ensure heinous offenders remain behind bars while cutting down on costs and maintaining public safety. In any sentencing reform legislation. Oppose the Prison Reform and Redemption Act (H.R. 3356) or any mangers amendment that is considered during the mark up. Any effort to pass prison reform (or back-end reform) legislation without including sentencing reform (or front-end reform) will not meaningfully improve the federal system Oppose HR 2152, the Citizens Right to Know Act as it raises serious privacy concerns. Support HR 1437, the No Money Bail Act which would incentivize jurisdictions to reform their money bail systems using federal resources. Support full funding for JJDPA programs in FY2019 Oppose H.R. 5698, the Protect and Serve Act of 2018, which creates a new crime for offenses that target law enforcement officers Oppose S. 2794, the Protect and Serve Act of 2018, which creates a new crime for offenses that target law enforcement officials Oppose HR 5682, the First Step Act, because it does not address sentencing reform; because of the Overbroad List of Exclusions; because to provides for a Dangerous Risk Assessment; because of The Absence of Funding for Implementation; because of the Undetermined Human and Fiscal Impact; because it contains a Misplaced Incentive System; and because of the Overbroad Discretion Provided to Attorney General Sessions Oppose judicial nominations of Andrew Oldham, Wendy Vitter, J. Campbell Barker, Michael Truncale, and Mark Norris due to their records of opposing critical legal protections for immigrant families. Oppose any efforts to reduce the fentanyl and analogue quantities in 21 U.S.C. 841 and 960, or to increase the lengths of these mandatory minimum sentences. Oppose S. 2635, either as a stand-alone bill or an amendment, which would mandate increased mandatory minimum sentences for fentanyl possession or sale. Oppose the policy of separating parents from children apprehended at the U.S. border Oppose HR 2851, the Stop Importation and Trafficking of Synthetic Analogues Act (SISTA) which would give AG Sessions sweeping, largely unchecked new powers to schedule new drugs and incarcerate more people Support the Prison Rape Elimination Act (PREA) and oppose the recent policy changes to the Bureau of Prisons Transgender Offender Manual Support S. 1728, the Private Prison Information /act, which would require for-profit prisons and detention centers to comply with the Freedom of Information Act (FOIA) Oppose Michael Brennan's nomination to the U.S. Court of Appeals for the Seventh Circuit Oppose the nomination of Stuart Kyle Duncan to the U.S. Court of Appeals for the Fifth Circuit Oppose the nomination of Andrew Oldham to the U.S. Court of Appeals for the Fifth Circuit Support H. Res. 285, Expressing the sense of the United States House of Representatives that Congress and the President should empower the creation of police and community alliances designed to enhance and improve communication and collaboration between members of the law enforcment community and the public they serve oppose H.R. 5682, the FIRST STEP Act. This bill, while containing several worthwhile proposals, should not be mistaken for what is needed. The FIRST STEP Act is not sentencing reform, and the concern -- a very valid concern -that enactment of this legislation will allow some lawmakers to say that they have addressed our nations problem of over-incarceration leads the NAACP to oppose this legislation. While we understand the temptation to support legislation that endeavors to reform our prison system, we believe that this particular bill would do more harm than good and would have unintended consequences that ripple into the future.
Client expense: $70,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Prisons (BOP), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Director of National Intelligence (ODNI), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Housing Finance Agency (FHFA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Credit Union Administration (NCUA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), State, Dept of (DOS), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2018 · second_quarter · Health Issues
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
Client expense: $104,269 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 878: Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 2851: Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act - Provisions related to controlled substances H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program HR 4993 Vaccine Access Improvement Act HR 4297/S 2103 Protecting Seniors Through Immunization Act H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5687: SOUND Disposal and Packaging Act - To require improved packaging and disposal methods with respect to certain drugs H.R. 6142: Reducing Drug Waste Act of 2018 - Action plan and report on vial size waste HR 6378/S 2852 Pandemic and All Hazards Preparedness Act reauthorization HR 6294 REVAMP Act S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1327: SITSA Act - Provisions related to controlled substances S. 2312: HELP Act - Provisions related to 340B program S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues 340B drug discount program policy issues 21st Century Cures Act (Public Law 114-255) - Provisions related to biopharmaceutical discovery, development, delivery, and transparency Senate HELP Committee Innovation Agenda - Provisions related to biopharmaceutical discovery and development of FDA policy TRICARE pharmacy pilot program Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49) Pandemic and All-Hazards Preparedness Act, provisions related to emerging infectious diseases and antimicrobial resistance. HR 6 - SUPPORT for Patients and Communities Act HR 5687 - SOUND Disposal and Packaging ActHR 5333 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 S 2315 - Over-the-Counter Drug Safety, Innovation, and Reform ActHR 394/S 85 - Restoring Access to Medication Act of 2017 HR 6199 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter medical products as qualified medical expenses. HR 6157 - FY19 Defense Appropriations ActS 3159 - FY19 Defense Appropriations ActS 3158 - FY19 Labor-HHS-Education Appropriations ActHouse Draft - FY19 Labor-HHS-Education Appropriations ActPatient Access in Medicaid program340B Discount Drug ProgramHR 4710 - 340B PAUSE ActHR 5598 - 340B Optimization Act HR 5958 - Phair Pricing Act of 2018
Client expense: $1,400,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
H.R. 2851 and S. 1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 Public Law No: 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Government Issues
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Controlled Substances Act reforms Stop the Importation and Trafficking of Synthetic Analogues Act, HR 2851 Industrial Hemp, HR 3530 Dietary Supplement Health & Education Act reforms
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
Client expense: Not reported · Firm income: $290,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 749: Lower Drug Costs through Competition Act - Provisions related to generic drug approvals H.R. 878: Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 1628: American Health Care Act of 2017 - Provisions related to the biopharmaceutical industry including repeal of brand pharmaceutical manufacturer fee and individual and employer mandates, insurance affordability provisions, and Medicaid reforms H.R. 1776: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 - Provisions related to labeling information describing abuse-deterrent properties H.R. 2026: Pharmaceutical Information Exchange Act - Provisions related to economic and scientific information communications H.R. 2051: FAST Generics Act of 2017 - Provisions related to REMS and limited distribution systems H.R. 2063: Opioid Preventing Abuse through Continuing Education (PACE) Act of 2017 - Provisions related to prescriber training H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 2851: Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act - Provisions related to controlled substances H.R. 3528: Every Prescription Conveyed Securely Act - e-Prescribing for coverage under part D of the Medicare program of prescription drugs that are controlled substances H.R. 3545: Overdose Prevention and Patient Safety Act - Provisions related to substance use disorder information sharing H.R. 3692: Addiction Treatment Access Improvement Act of 2017 - Provisions related to medication assisted treatment (MAT) access H.R. 4275: Empowering Pharmacists in the Fight Against Opioid Abuse Act - Provisions related to pharmacist education H.R. 4284: Indexing Narcotics, Fentanyl, and Opioids (INFO) Act of 2017 - Provisions related to substance data collection H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program H.R. 4482: Opioid Abuse Deterrence, Research, and Recovery Act of 2017 - Provisions related to prescriber requirements H.R. 5002: Advancing Cutting Edge Research Act - Provisions related to non-addiction pain medication H.R. 5009: Jessies Law - Provisions related to patient information sharing H.R. 5041: The Safe Disposal of Unused Medication Act - Provisions related to drug disposal H.R. 5102: Substance Use Disorder Workforce Loan Repayment Act of 2018 - Provisions related to student loan repayment to substance use disorder (SUD) providers H.R. 5150: Protecting Medicare from Excessive Price Increases Act of 2018 - To require drug manufacturers to pay a Medicare part B rebate for certain drugs H.R. 5151: To amend the Public Health Service Act to reauthorize a grant program improving treatment for pregnant and postpartum women H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 - Provisions related to drug delivery H.R. 5228: SCREEN Act - Provisions related to drug recall authority H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 5261: Treatment, Education, and Community Help to Combat Addiction Act of 2018 - Provisions related to grants for substance use disorder (SUD) prevention, treatment, and recovery H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5327: Comprehensive Opioid Recovery Centers Act of 2018 - Provisions related to opioid recovery center grants H.R. 5329: Poison Center Network Enhancement Act of 2018 - Provisions related to national poison center funding and other prevention funding H.R. 5353: Eliminating Opioid Related Infectious Diseases Act of 2018 - Provisions related to CDC infection surveillance and other funding H.R. 5477: Rural DOCS Act - To provide for a demonstration project to increase substance use provider capacity under the Medicaid program H.R. 5580: STOP Fentanyl Deaths Act of 2018 - To authorize the Secretary of Health and Human Services to conduct programs to address the usage of illicit drugs, particularly fentanyl H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5676: Stop Excessive Narcotics in our Retirement Communities Protection Act of 2018 - To authorize the suspension of payments by Medicare prescription drug plans and MA-PD plans pending investigations of credible allegations of fraud by pharmacies H.R. 5687: SOUND Disposal and Packaging Act - Provisions related to packaging and disposal methods with respect to certain drugs H.R. 5711: Improving Access to Mental Health Services Act - To allow National Health Service Corps members to provide obligated service as behavioral and mental health professionals at schools, other community-based settings, or patient homes H.R. 5723: Expanding Oversight of Opioid Prescribing and Payment Act of 2018 - To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program H.R. 5752: Stop Illicit Importation Act of 2018 - Provisions related to importation H.R. 5762: Joint Task Force to Combat Opioid Trafficking Act of 2018 - To authorize a Joint Task Force to enhance integration of the Department of Homeland Securitys border security operations to detect, interdict, disrupt, and prevent narcotics, such as fentanyl and other synthetic opioids, from entering the United States H.R. 5774: Combating Opioid Abuse for Care in Hospitals Act of 2018 - Provisions related to opioids H.R. 5775: Providing Reliable Options for Patients and Educational Resources Act of 2018 - To require Medicare Advantage plans and part D prescription drug plans to include information on the risks associated with opioids, coverage of certain nonopioid treatments used to treat pain, and on the safe disposal of prescription drugs H.R. 5796: Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment (REACH OUT) Act of 2018 - To require the Secretary of Health and Human Services to provide grants for eligible entities to provide technical assistance to outlier prescribers of opioids H.R. 5803: SAFETY Act of 2018 - Provisions related to drug approval H.R. 5811: Long-Term Opioid Efficacy Act of 2018 - Postapproval study requirements H.R. 6071: SERV Communities Act - Provisions related to transparency in the 340B program H.R. 6110: Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018' H.R. 6142: Reducing Drug Waste Act of 2018 - Action plan and report on vial size waste S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 771: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 - Provisions related to drug pricing S. 1327: SITSA Act - Provisions related to controlled substances S. 2312: HELP Act - Provisions related to 340B program S. 2406: ACE Research Act - Research initiatives of the NIH S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program S. 2553: Know the Lowest Price Act of 2018 - Provisions related to drug pricing S. 2554: Patient Right to Know Drug Prices Act - Provisions related to drug pricing S. 2589: Comprehensive Opioid Recovery Centers Act of 2018 - Provisions related to CDC infection surveillance and other funding S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety S. 2680: Opioid Crisis Response Act of 2018 - Provisions related to opioids S. 2842: Opioid Addiction Recovery Fraud Prevention Act of 2018 - Provisions related to opioid treatment programs or products S. __: Drug Accepted Use Labeling Act of 2018 - Provisions related to labeling Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Generic drug approval process policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues Limited distribution systems in the pharmaceutical supply chain policy issues FDA modernization policy issues 340B drug discount program policy issues 21st Century Cures Act (Public Law 114-255) - Provisions related to biopharmaceutical discovery, development, delivery, and transparency Senate HELP Committee Innovation Agenda - Provisions related to biopharmaceutical discovery and development of FDA policy Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug compounding policy issues including federal oversight of compounded drugs Cancer drug vial size policy issues TRICARE pharmacy pilot program Opioids shortages policy issues Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49)
Client expense: $5,540,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Alcohol and Drug Abuse
S. 1327, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R. 2851, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R.993, Opioid Abuse Prevention and Treatment Act of 2017
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Monitor and advocate on legislative and regulatory issues regarding healthcare. H.R. 6, SUPPORT for Patients and Communities Act. H.R. 541, Improving Oversight and Accountability in Medicaid Non-DSH Supplemental Payments Act. H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 2038, Budgeting for Opioid Addiction Treatment Act. H.R. 2843, Medicaid and CHIP Quality Improvement Act of 2017. H.R. 2851, SITSA Act. H.R. 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. H.R. 4710, 340B PAUSE Act. H.R. 5795, Overdose Prevention and Patient Safety Act. H.R. 5797, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act. H.R. 6082, Overdose Prevention and Patient Safety Act. S. 155, RAISE Act. S.413, Improving Transparency and Accuracy in Medicare Part D Spending Act. S. 523, Budgeting for Opioid Addiction Treatment Act. S. 1079, Protecting Americans from Dangerous Opioids Act. S. 1123, Office of National Drug Control Policy Reauthorization Act of 2017. S. 1317, Medicaid and CHIP Quality Improvement Act of 2017. S. 2453, Ensuring the Value of the 340B Program Act of 2018. S. 2680, Opioid Crisis Response Act of 2018.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2018 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 2851, SITSA Act: Entire bill H.R. 3356, Prison Reform and Redemption Act: Entire bill H.R. 4261, SAFE Justice Act: Entire bill H.R. 5682, FIRST STEP Act: Entire bill H.R. 5698, Protect and Serve Act: Entire bill PN 1672, Henry E. Hudson - United States Sentencing Commission: N/A PN 1673, William Graham Otis - United States Sentencing Commission: N/A S. 1917, Sentencing Reform and Corrections Act: Entire bill S. 3118, Mens Rea Reform Act: Entire bill
Client expense: $680,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2018 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R.3356 - Prison Reform and Redemption Act H.R.5682 - FIRST STEP Act S.2795 - FIRST STEP Act H.R.2851 - SITSA Act S.1327 - SITSA Act H.R.2899 - Second Chance Reauthorization Act of 2017 (and not yet reintroduced Senate companion) S.1856 - Stop Militarizing Law Enforcement Act H.R.1556 - Stop Militarizing Law Enforcement Act S.827 - REDEEM Act H.R.1906 - REDEEM Act Package of campaign finance reforms as yet to be introduced in the House of Representatives S. 860, Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions H.R.1809 - Juvenile Justice Reform Act of 2017 H.R. 3713 - Sentencing Reform Act of 2015, all provisions (114th Congress) S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE